These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8195453)

  • 21. Propranolol in the treatment of assaultive patients with organic brain disease.
    Greendyke RM; Schuster DB; Wooton JA
    J Clin Psychopharmacol; 1984 Oct; 4(5):282-5. PubMed ID: 6490964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-directed and other-directed aggressive behavior in a forensic sample.
    Hillbrand M
    Suicide Life Threat Behav; 1992; 22(3):333-40. PubMed ID: 1440747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial.
    Sival RC; Haffmans PM; Jansen PA; Duursma SA; Eikelenboom P
    Int J Geriatr Psychiatry; 2002 Jun; 17(6):579-85. PubMed ID: 12112183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproic acid treatment of episodic explosiveness related to brain injury.
    Geracioti TD
    J Clin Psychiatry; 1994 Sep; 55(9):416-7. PubMed ID: 7929025
    [No Abstract]   [Full Text] [Related]  

  • 25. Clozapine response and adverse effects in nine brain-injured patients.
    Michals ML; Crismon ML; Roberts S; Childs A
    J Clin Psychopharmacol; 1993 Jun; 13(3):198-203. PubMed ID: 8354736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
    Jagannathan V; Venitz J
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paramenstrual aggression in mentally retarded adult ameliorated by buspirone.
    Colella RF; Ratey JJ; Glaser AI
    Int J Psychiatry Med; 1992; 22(4):351-6. PubMed ID: 1293064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buspirone in social phobia.
    Schneier FR; Saoud JB; Campeas R; Fallon BA; Hollander E; Coplan J; Liebowitz MR
    J Clin Psychopharmacol; 1993 Aug; 13(4):251-6. PubMed ID: 8376612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.
    Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC
    Clin Ther; 2006 Oct; 28(10):1695-700. PubMed ID: 17157125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda.
    Connor DF; Carlson GA; Chang KD; Daniolos PT; Ferziger R; Findling RL; Hutchinson JG; Malone RP; Halperin JM; Plattner B; Post RM; Reynolds DL; Rogers KM; Saxena K; Steiner H;
    J Clin Psychiatry; 2006 May; 67(5):808-20. PubMed ID: 16841631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series.
    Saxena K; Chang K; Steiner H
    Bipolar Disord; 2006 Aug; 8(4):405-10. PubMed ID: 16879141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital.
    Ratey JJ; Leveroni C; Kilmer D; Gutheil C; Swartz B
    J Clin Psychiatry; 1993 Jun; 54(6):219-23. PubMed ID: 8331090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach.
    Mintzer JE; Brawman-Mintzer O
    J Clin Psychiatry; 1996; 57 Suppl 7():55-63; discussion 73-5. PubMed ID: 8690698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open trial of buspirone in the treatment of attention-deficit disorder.
    Niederhofer H
    Hum Psychopharmacol; 2003 Aug; 18(6):489-92. PubMed ID: 12923830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological brain ageing: evaluation of the efficacy of a pharmacological aid.
    Guarnaschelli C; Fugazza G; Pistarini C
    Drugs Exp Clin Res; 1988; 14(11):715-8. PubMed ID: 3246216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavior management of aggressive sequela after Reye's syndrome.
    Jacobs HE; Lynch M; Cornick J; Slifer K
    Arch Phys Med Rehabil; 1986 Aug; 67(8):558-63. PubMed ID: 2874781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression.
    Pfeffer CR; Jiang H; Domeshek LJ
    J Child Adolesc Psychopharmacol; 1997; 7(3):145-55. PubMed ID: 9466232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of Japanese herbal medicine yokukansan for alleviating psychiatric symptoms after traumatic brain injury.
    Saito S; Kobayashi T; Osawa T; Kato S
    Psychogeriatrics; 2010 Mar; 10(1):45-8. PubMed ID: 20594286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose buspirone to treat agitation and maladaptive behavior in brain-injured patients: two case reports.
    Ratey JJ; Leveroni CL; Miller AC; Komry V; Gaffar K
    J Clin Psychopharmacol; 1992 Oct; 12(5):362-4. PubMed ID: 1479058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.